These results indicated that ALDH levels is sufficient to define a subpopulation of pancreatic cancer cells that demonstrates poor differentiation, repopulating abilities, resistance to gemcitabine, and greater tumorigenicity, which are compatible with the typical features of CSCs. This evidence concerns the gene LDHA and familial pancreatic carcinoma.